You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

prostate cancer, abiraterone, apalutamide

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Prostate Cancer
  • Leuprolide acetate
  • +9 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2022

Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)

Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Phoenix, Arizona
  • +183 more
Jan 17, 2023

Prostate Cancer Trial in United States (ARN-509, Abiraterone, Leuprolide)

Active, not recruiting
  • Prostate Cancer
  • Baltimore, Maryland
  • +10 more
Feb 8, 2022

Prostatic Tumors, Castration-Resistant Trial (Abiraterone, Apalutamide)

Withdrawn
  • Prostatic Neoplasms, Castration-Resistant
  • (no location specified)
Nov 15, 2020

Oligometastatic Hormone Sensitive Prostate Cancer Trial in Florence (SBRT on all sites of metastatic disease+Apalutamide)

Not yet recruiting
  • Oligometastatic Hormone Sensitive Prostate Cancer
  • SBRT on all sites of metastatic disease+Apalutamide
  • Florence, Italy
    AOU Careggi Radiation Oncology Unit
Jan 29, 2023

Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)

Recruiting
  • Prostate Cancer
  • +4 more
  • PET-directed Local Therapy using Surgery
  • +10 more
  • Long Beach, California
  • +15 more
Jul 29, 2022

Prostate Cancer Trial in Chicago (Docetaxel, ADT, Abiraterone)

Not yet recruiting
  • Prostate Cancer
  • Chicago, Illinois
    Northwestern University
Sep 27, 2023

Darolutamide, Enzalutamide and Apalutamide and How Well These

Not yet recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Whippany, New Jersey
    Bayer
Aug 25, 2023

Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer
  • (no location specified)
Nov 10, 2023

Prostate Cancer With =10 Bone Metastases Trial (Apalutamide, 89Sr, Luteinizing Hormone-Releasing Hormone Analog)

Not yet recruiting
  • Prostate Cancer With ≤10 Bone Metastases
  • (no location specified)
Feb 22, 2023

Called DEAR, to Learn More About Treatment With Darolutamide,

Active, not recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Darolutamide (Nubeqa, BAY1841788)
  • +2 more
  • Whippany, New Jersey
    Bayer
Jan 13, 2023

Apalutamide in Metastatic Hormone Sensitive Prostate Cancer

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
    • Cardiff, United Kingdom
    • +4 more
    Aug 25, 2023

    Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

    Active, not recruiting
    • Prostatic Neoplasms
    • Beijing, China
    • +3 more
    Jan 17, 2023

    Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Enzalutamide 40 MG, Docetaxel injection)

    Not yet recruiting
    • Prostate Cancer
    • Castrate Resistant Prostate Cancer
    • Enzalutamide 40 MG
    • Docetaxel injection
    • (no location specified)
    Jan 27, 2023

    Castration-resistant Prostate Cancer Trial in Los Angeles (Apalutamide, Carotuximab)

    Not yet recruiting
    • Castration-resistant Prostate Cancer
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Sep 6, 2022

    Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)

    Recruiting
    • Prostate Cancer
    • Prostate Cancer Metastatic
    • La Jolla, California
    • +1 more
    Feb 2, 2023

    Prostate Cancer Trial in Tampa (Abiraterone Acetate)

    Active, not recruiting
    • Prostate Cancer
    • Abiraterone Acetate
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 3, 2023

    Prostate Cancer Trial (Dutasteride, Abiraterone)

    Not yet recruiting
    • Prostate Cancer
    • (no location specified)
    Jan 30, 2023

    Medicines Called Enzalutamide and Abiraterone in People With

    Not yet recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • New York, New York
      Pfizer Inc
    Jul 21, 2023

    Prostate Cancer Trial in Cincinnati (Apalutamide Oral Product, Androgen Deprivation Therapy (ADT), Focal Therapy)

    Not yet recruiting
    • Prostate Cancer
    • Apalutamide Oral Product
    • +2 more
    • Cincinnati, Ohio
      University of Cincinnati Medical Center
    Mar 27, 2023

    Metastatic Castrate-sensitive Prostate Cancer Trial in Germany, United States (Apalutamide, Androgen-deprivation Therapy (ADT))

    Not yet recruiting
    • Metastatic Castrate-sensitive Prostate Cancer
    • Lakewood, Colorado
    • +5 more
    May 23, 2023

    Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer (mCRPC)
    • Prostatic Neoplasms
    • (no location specified)
    Nov 21, 2023

    Localized Prostate Carcinoma, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 Trial in United States (Apalutamide,

    Recruiting
    • Localized Prostate Carcinoma
    • +8 more
    • Tucson, Arizona
    • +4 more
    Jun 28, 2022

    Prostate Cancer Trial (Neoadjuvant treatment)

    Not yet recruiting
    • Prostate Cancer
    • Neoadjuvant treatment
    • (no location specified)
    Oct 19, 2022

    Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • Prostate Adenocarcinoma
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 20, 2023